181 related articles for article (PubMed ID: 31652152)
21. CXCR4 WHIM syndrome is a cancer predisposition condition for virus-induced malignancies.
Moulin C; Beaupain B; Suarez F; Bertrand Y; Beaussant SC; Fischer A; Durin J; Ranta D; Espéli M; Bachelerie F; Bellanné-Chantelot C; Molina T; Emile JF; Balabanian K; Deback C; Donadieu J
Br J Haematol; 2024 Apr; 204(4):1383-1392. PubMed ID: 38442908
[TBL] [Abstract][Full Text] [Related]
22. WHIM syndrome: congenital immune deficiency disease.
Kawai T; Malech HL
Curr Opin Hematol; 2009 Jan; 16(1):20-6. PubMed ID: 19057201
[TBL] [Abstract][Full Text] [Related]
23. A Sherlock Approach to a Kindred With a Variable Immunohematologic Phenotype.
Walkovich K; Grunebaum E
J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1714-1722. PubMed ID: 35470097
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
[TBL] [Abstract][Full Text] [Related]
25. [Late diagnosis of WHIM sydrome].
Paolini MV; Danielian S; Prieto E; Tami MF; Oleastro MM; Fernández Romero DS
Medicina (B Aires); 2018; 78(2):123-126. PubMed ID: 29659363
[TBL] [Abstract][Full Text] [Related]
26. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
27. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
Bachelerie F
Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
[TBL] [Abstract][Full Text] [Related]
28. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
[TBL] [Abstract][Full Text] [Related]
29. Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
Merati N; Sivachandran S; Jfri A; Ben-Shoshan M; Vinh DC; Popradi G; Litvinov IV
Skin Therapy Lett; 2022 Mar; 27(2):1-5. PubMed ID: 35385630
[TBL] [Abstract][Full Text] [Related]
30. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
[TBL] [Abstract][Full Text] [Related]
31. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
Tassone L; Moratto D; Vermi W; De Francesco M; Notarangelo LD; Porta F; Lougaris V; Facchetti F; Plebani A; Badolato R
Blood; 2010 Dec; 116(23):4870-3. PubMed ID: 20736454
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.
Hernandez PA; Gorlin RJ; Lukens JN; Taniuchi S; Bohinjec J; Francois F; Klotman ME; Diaz GA
Nat Genet; 2003 May; 34(1):70-4. PubMed ID: 12692554
[TBL] [Abstract][Full Text] [Related]
33. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
34. Plerixafor for the Treatment of WHIM Syndrome.
McDermott DH; Pastrana DV; Calvo KR; Pittaluga S; Velez D; Cho E; Liu Q; Trout HH; Neves JF; Gardner PJ; Bianchi DA; Blair EA; Landon EM; Silva SL; Buck CB; Murphy PM
N Engl J Med; 2019 Jan; 380(2):163-170. PubMed ID: 30625055
[TBL] [Abstract][Full Text] [Related]
35. Adaptive Immunodeficiency in WHIM Syndrome.
Majumdar S; Murphy PM
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577453
[TBL] [Abstract][Full Text] [Related]
36. TREC Screening for WHIM Syndrome.
Evans MO; Petersen MM; Khojah A; Jyonouchi SC; Edwardson GS; Khan YW; Connelly JA; Morris D; Majumdar S; McDermott DH; Walter JE; Murphy PM
J Clin Immunol; 2021 Apr; 41(3):621-628. PubMed ID: 33415666
[TBL] [Abstract][Full Text] [Related]
37. [Early detection of WHIM symdrome. A case report].
Macías-Robles AP; Tlacuilo-Parra A; Asencio-Gallegos AE; de la Herrán-Arita BK; Lugo-Reyes SO
Rev Alerg Mex; 2023 May; 70(1):47-50. PubMed ID: 37566756
[TBL] [Abstract][Full Text] [Related]
38. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
McDermott DH; Liu Q; Ulrick J; Kwatemaa N; Anaya-O'Brien S; Penzak SR; Filho JO; Priel DA; Kelly C; Garofalo M; Littel P; Marquesen MM; Hilligoss D; Decastro R; Fleisher TA; Kuhns DB; Malech HL; Murphy PM
Blood; 2011 Nov; 118(18):4957-62. PubMed ID: 21890643
[TBL] [Abstract][Full Text] [Related]
39. Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation.
Sanmun D; Garwicz D; Smith CI; Palmblad J; Fadeel B
Br J Haematol; 2006 Sep; 134(6):640-4. PubMed ID: 16899028
[TBL] [Abstract][Full Text] [Related]
40. [WHIM syndrome: a case report and literature review].
Chen XJ; Yang WY; Wang SC; Guo Y; Liu F; Qi BQ; Chang LX; Zhou JF; An WB; Wei W; Wan Y; Zhu XF
Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):178-82. PubMed ID: 23751577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
